SMPD1 and diabetes mellitus: Since we previously found cellular ASM levels to be increased using in vitro model of diabetes [11], we hypothesized that ASM activation could also take place in EPCs in diabetes, altering sphingolipid content of EPC plasma membranes and resulting in decreased EPC migration ability.